Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
14.8M
-
Shares change
-
+14.4M
-
Total reported value, excl. options
-
$400M
-
Value change
-
+$389M
-
Number of buys
-
62
-
Price
-
$27.34
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2014
65 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2014.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.8M shares
of 101M outstanding shares and own 14.67% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (2.49M shares), OZ Management LP (1.32M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.2M shares), FMR LLC (1.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (979K shares), WADDELL & REED FINANCIAL INC (971K shares), PointState Capital LP (879K shares), Visium Asset Management, LP (789K shares), JPMORGAN CHASE & CO (763K shares), and JANUS CAPITAL MANAGEMENT LLC (539K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.